Wockhardt, founded in 1967, now has six novel formulations in the pipeline, with a second drug Zaynich also expected to ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with heart disease.

Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.

Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM® (monomethyl fumarate) product for the treatment of ...

Can Walgreens Boots Alliance stock continue rising, or should investors use the stock's recent gain as an opportunity to exit ...

Rare Disease Segment performed in line with expectations, with Purified Cortrophin Gel net revenues of $197.8 million to $198 ...

In this Q&A, Joe Dorazio, Small Group Head of Sales – at Aetna ®, a CVS Health ® Company, addresses common questions about ...